益心舒膠囊治療房性早搏臨床研究-文庫(kù)吧
2024-12-24 10:29 本頁(yè)面
【正文】 patients were not patients received Yixinshu tid po bined with isoptin as trial group studying for 4 patients received isoptin alone 40mg tid po as controlled group studying for 4 monitored the times of atrial premature beats before and after The result of Holter after treating 4 weeks act as the level between two trial group:the total efficacy rate of Yixinshu bined with isoptin was 90%.The times of APB dropped very obvious from (5088177。4258) times/24h to (1274177。1671) times/ stastical difference was very obviously before treatment and after treatment.(P＜ ).The control group:the total efficacy rate of isoptin was 66%,the times of APB dropped very obvious from (5039177。 3102) times/24h to (2229177。 1829) KKME專(zhuān)業(yè)醫(yī)學(xué)搜索引擎 times/ statistical difference was very obviously before treatment and after treatment (P＜ ).There was statistical diffierence in two groups (P＜ ).Conclusion The efficacy of Yixinshu bined with isoptin in treating APB was very obvious,and was better than that of isoptin alone. 【 Key words】 Yixinshu。isoptin。atrial premature beats 房性早搏是一種激動(dòng)起源于竇房結(jié)外，心房任何部位的心律失常。臨床多見(jiàn)于正常人群和患有各種器質(zhì)性心臟病的患者。目前認(rèn)為無(wú)癥狀的房性早搏無(wú)需治療。有癥狀的房早患者可口服抗心律失常藥物，如：異搏定、普羅帕酮等。益心舒是一種治療冠心病，改善心肌供血的中成藥。本研究旨在探討益心舒聯(lián)合異搏定治療房性早搏的有效性和安全性。 1 資料與方法 試驗(yàn)設(shè)計(jì) 用隨機(jī)、單盲、平行對(duì)照試驗(yàn)方法。 一般資料 入選標(biāo)準(zhǔn) 選擇 2022
公司管理相關(guān)推薦
鄂ICP備17016276號(hào)-1